Chemical intervention in signalling networks: Recent advances and applications

Signal Transduction

Volumn 6, Issue 2, 2006, Pages 144-159

  Tate, Edward William ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chemical genetics; Membrane biology; Protein ligand engineering; Structure guided design; Systems biology

Indexed keywords

ANANDAMIDE; ANTIBIOTIC AGENT; AUXIN; BAMBERMYCIN; CANNABINOID; CHEMICAL AGENT; FATTY ACID AMIDASE; FK 506 BINDING PROTEIN; GENE PRODUCT; LIPID; MEMBRANE PROTEIN; OLEAMIDE; PEPTIDE; PROTEIN KINASE; RAPAMYCIN; VANCOMYCIN;

ANALGESIA; BACTERIAL OUTER MEMBRANE; BIOLOGY; CHEMICAL GENETICS; CHEMICAL REACTION; CYTOLOGY; DRUG INHIBITION; HIGH THROUGHPUT SCREENING; HUMAN; IMAGING; MEMBRANE BIOLOGY; MICROARRAY ANALYSIS; MOLECULAR PROBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SYNTHESIS; ULTRAVIOLET RADIATION;

BACTERIA (MICROORGANISMS);

EID: 33646372429     PISSN: 16154053     EISSN: 16154061     Source Type: Journal    
DOI: 10.1002/sita.200500075     Document Type: Review

References (130)

1. Aderem, A. (2005) Systems biology: its practice and challenges. Cell 121: 511-513.
2. Liu, E.T. (2005) Systems biology, integrative biology, predictive biology. Cell 121: 505-506.
3. Kirschner, M.W. (2005) The meaning of systems biology. Cell 121: 503-504.
4. Rousseau, F., Schymkowitz, J. (2005) A systems biology perspective on protein structural dynamics and signal transduction. Curr. Opin. Struct. Biol. 15: 23-30.
5. Sharom, J.R., Bellows, D.S., Tyers, M. (2004) From large networks to small molecules. Curr. Opin. Chem. Biol. 8: 81-90.
6. Kolch, W., Calder, M., Gilbert, D. (2005) When kinases meet mathematics: the systems biology of MAPK signalling. FEBS Lett. 579: 1891-1895.
7. von Euler, H., Hellstrom, H., Lofgren, N. (1935) Chemical genetics of chlorophyll-mutating barley stains. Comparison between the chlorophyll and gramine content in the strains Primus I, Primus II (gulvit, xanthalba and Xanthaurea), Westergaard's line and a line from the crossing of Goldgerste with Chevalier. Physiol. Chem. 234: 151-164.
8. Schreiber, S.L. (1998) Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6: 1127-1152.
9. Bishop, A., Buzko, O., Heyeck-Dumas, S., Jung, I., Kraybill, B., Liu, Y., Shah, K., Ulrich, S., Witucki, L., Yang, F., Zhang, C., Shokat, K.M. (2000) Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu. Rev. Biophys. Biomol. Struct. 29: 577-606.
10. Mitchison, T.J. (1994) Towards a pharmacological genetics. Chem. Biol. 1: 3-6.
11. Harrigan, G.G., Brackett, D.J., Boros, L.G. (2005) Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. Mini. Rev. Med. Chem. 5: 13-20.
12. Piggott, A.M., Karuso, P. (2004) Quality, not quantity: the role of natural products and chemical proteomics in modern drug discovery. Comb. Chem. High Throughput Screen. 7: 607-630.
13. Shim, J.S., Kwon, H.J. (2004) Chemical genetics for therapeutic target mining. Expert. Opin. Ther. Targets 8: 653-661.
14. Carroll, P.M., Dougherty, B., Ross-Macdonald, P., Browman, K., FitzGerald, K. (2003) Model systems in drug discovery: chemical genetics meets genomics. Pharmacol. Ther. 99: 183-220.
15. Khersonsky, S.M., Chang, Y.T. (2004) Forward chemical genetics: library scaffold design. Comb. Chem. High Throughput. Screen. 7: 645-652.
16. Khersonsky, S.M., Chang, Y.T. (2004) Strategies for facilitated forward chemical genetics. Chembiochem. 5: 903-908.
17. Thorpe, D.S. (2003) Forward & reverse chemical genetics using SPOS-based combinatorial chemistry. Comb. Chem. High Throughput Screen. 6: 623-647.
18. Lokey, R.S. (2003) Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia. Curr. Opin. Chem. Biol. 7: 91-96.
19. Tochtrop, G.P., King, R.W. (2004) Target identification strategies in chemical genetics. Comb. Chem. High Throughput Screen. 7: 677-688.
20. Shah, K. (2005) Orthogonal chemical genetic approaches for unraveling signaling pathways. IUBMB Life 57: 397-405.
21. Shokat, K., Velleca, M. (2002) Novel chemical genetic approaches to the discovery of signal transduction inhibitors. Drug Discov. Today 7: 872-879.
22. Beeler, A.B., Schaus, S.E., Porco, J.A., Jr. (2005) Chemical library synthesis using convergent approaches. Curr. Opin. Chem. Biol 9: 277-284.
23. Schreiber, S.L. (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287: 1964-1969.
24. Shang, S., Tan, D.S. (2005) Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries. Curr. Opin. Chem. Biol. 9: 248-258.
25. Colca, J.R., Harrigan, G.G. (2004) Photo-affinity labeling strategies in identifying the protein ligands of bioactive small molecules: examples of targeted synthesis of drug analog photoprobes. Comb. Chem. High Throughput. Screen. 7: 699-704.
26. Mestres, J. (2004) Computational chemogenomics approaches to systematic knowledge-based drug discovery. Curr. Opin. Drug Discov. Devel. 7: 304-313.
27. Lipinski, C., Hopkins, A. (2004) Navigating chemical space for biology and medicine. Nature 432: 855-861.
28. Oprea, T.I. (2002) Chemical space navigation in lead discovery. Curr. Opin. Chem. Biol. 6: 384-389.
29. Haggarty, S.J., Clemons, P.A., Wong, J.C., Schreiber, S.L. (2004) Mapping chemical space using molecular descriptors and chemical genetics: deacetylase inhibitors. Comb. Chem. High Throughput Screen. 7: 669-676.
30. Reayi, A., Arya, P. (2005) Natural product-like chemical space: search for chemical dissectors of macromolecular interactions. Curr. Opin. Chem. Biol. 9: 240-247.
31. Boldi, A.M. (2004) Libraries from natural product-like scaffolds. Curr. Opin. Chem. Biol. 8: 281-286.
32. Ortholand, J.Y., Ganesan, A. (2004) Natural products and combinatorial chemistry: back to the future. Curr. Opin. Chem. Biol. 8: 271-280.
33. Tate, E.W., Kulai, C., Zard, S.Z. (2002) A short formal route to (±)-lepadin B using a xanthate-mediated free radical cyclisation/ vinylation sequence. Chemical Communications 13: 1430-1431.
34. Dixon, D.J., Ley, S.V., Tate, E.W. (1998) A total synthesis of (+)-Goniodiol using an anomeric oxygen-to-carbon rearrangement. Journal of the Chemical Society, Perkin Transactions 1 19: 3125-3126.
35. Tate, E.W., Zard, S.Z. (2002) Efficient construction of polycyclic alkaloid synthetic precursors by a xanthate free radical addition and Mannich cyclisation cascade. Tetrahedron Letters 43: 4683-4686.
36. Nicolaou, K.C., Baran, P.S. (2002) The CP molecule labyrinth: a paradigm of how endeavors in total synthesis lead to discoveries and inventions in organic synthesis. Angew. Chem. Int. Ed. Engl. 41: 2678-2720.
37. Haggarty, S.J. (2005) The principle of complementarity: chemical versus biological space. Curr. Opin. Chem. Biol. 9: 296-303.
38. McBride, J.D., Leatherbarrow, R.J. (2001) Synthetic peptide mimics of the Bowman-Birk inhibitor protein. Curr. Med. Chem. 8: 909-917.
39. McBride, J.D., Freeman, N., Domingo, G.J., Leatherbarrow, R.J. (1996) Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library. J. Mol. Biol. 259: 819-827.
40. Horswill, A.R., Benkovic, S.J. (2005) Cyclic peptides, a chemical genetics tool for biologists. Cell Cycle 4: 552-555.
41. Spencer, D.M., Wandless, T.J., Schreiber, S.L., Crabtree, G.R. (1993) Controlling signal transduction with synthetic ligands. Science 262: 1019-1024.
42. Holsinger, L.J., Spencer, D.M., Austin, D.J., Schreiber, S.L., Crabtree, G.R. (1995) Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA 92: 9810-9814.
43. Belshaw, P.J., Ho, S.N., Crabtree, G.R., Schreiber, S.L. (1996) Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl. Acad. Sci. USA 93: 4604-4607.
44. Moskowitz, H.S., Heuser, J., McGraw, T.E., Ryan, T.A. (2003) Targeted chemical disruption of clathrin function in living cells. Mol. Biol. Cell 14: 4437-4447.
45. de Graffenried, C.L., Laughlin, S.T., Kohler, J.J., Bertozzi, C.R. (2004) A small-molecule switch for Golgi sulfotransferases. Proc. Natl. Acad. Sci. USA 101: 16715-16720.
46. Luker, K.E., Smith, M.C., Luker, G.D., Gammon, S.T., Piwnica-Worms, H., Piwnica-Worms, D. (2004) Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. USA 101: 12288-12293.
47. Zhao, Y., Dai, X., Blackwell, H.E., Schreiber, S.L., Chory, J. (2003) SIR1, an upstream component in auxin signaling identified by chemical genetics. Science 301: 1107-1110.
48. Weijers, D., Jurgens, G. (2004) Funneling auxin action: specificity in signal transduction. Curr. Opin. Plant Biol. 7: 687-693.
49. Hayashi, K., Jones, A.M., Ogino, K., Yamazoe, A., Oono, Y., Inoguchi, M., Kondo, H., Nozaki, H. (2003) Yokonolide B, a novel inhibitor of auxin action, blocks degradation of AUX/IAA factors. J. Biol. Chem. 278: 23797-23806.
50. Carter, C.J., Bednarek, S.Y., Raikhel, N.V. (2004) Membrane trafficking in plants: new discoveries and approaches. Curr. Opin. Plant Biol. 7: 701-707.
51. Zouhar, J., Hicks, G.R., Raikhel, N.V. (2004) Sorting inhibitors (Sortins): Chemical compounds to study vacuolar sorting in Arabidopsis. Proc. Natl. Acad. Sci. USA 101: 9497-9501.
52. Dubos, C., Willment, J., Huggins, D., Grant, G.H., Campbell, M.M. (2005) Kanamycin reveals the role played by glutamate receptors in shaping plant resource allocation. Plant J. 43: 348-355.
53. Shokat, K.M. (2005) Chemicals call bacteria, and a new membrane protein machine answers. Cell 121: 163-166.
54. Eggert, U.S., Ruiz, N., Falcone, B.V., Branstrom, A.A., Goldman, R.C., Silhavy, T.J., Kahne, D. (2001) Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. Science 294: 361-364.
55. Ruiz, N., Falcone, B., Kahne, D., Silhavy, T.J. (2005) Chemical conditionality: a genetic strategy to probe organelle assembly. Cell 121: 307-317.
56. Wu, T., Malinverni, J., Ruiz, N., Kim, S., Silhavy, T.J., Kahne, D. (2005) Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli. Cell 121: 235-245.
57. Nikaido, H. (2005) Restoring permeability barrier function to outer membrane. Chem. Biol. 12: 507-509.
58. Boger, D.L., Sato, H., Lerner, A.E., Guan, X., Gilula, N.B. (1999) Arachidonic acid amide inhibitors of gap junction cell-cell communication. Bioorg. Med. Chem. Lett. 9: 1151-1154.
59. Cravatt, B.F., Prospero-Garcia, O., Siuzdak, G., Gilula, N.B., Henriksen, S.J., Boger, D.L., Lerner, R.A. (1995) Chemical characterization of a family of brain lipids that induce sleep. Science 268: 1506-1509.
60. Laposky, A.D., Homanics, G.E., Basile, A., Mendelson, W.B. (2001) Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport 12: 4143-4147.
61. van der, S.M., Trevisani, M., Vellani, V., De, P.L., Schiano, M.A., Campi, B., McNaughton, P., Geppetti, P., Di, M. V (2005) Anandamide acts as an intracellular messenger amplifying Ca(2+) influx via TRPV1 channels. EMBO J.
62. Mechoulam, R., Fride, E., Hanus, L., Sheskin, T., Bisogno, T., Di, M., V, Bayewitch, M., Vogel, Z. (1997) Anandamide may mediate sleep induction. Nature 389: 25-26.
63. Di, M., V, Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.C., Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691.
64. Lichtman, A.H., Hawkins, E.G., Griffin, G., Cravatt, B.F. (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther. 302: 73-79.
65. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A., Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87.
66. Boger, D.L., Sato, H., Lerner, A.E., Hedrick, M.P., Fecik, R.A., Miyauchi, H., Wilkie, G.D., Austin, B.J., Patricelli, M.P., Cravatt, B.F. (2000) Exceptionally potent inhibitors of fatty add amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. USA 97: 5044-5049.
67. Boger, D.L., Miyauchi, H., Du, W., Hardouin, C., Fecik, R.A., Cheng, H., Hwang, I., Hedrick, M.P., Leung, D., Acevedo, O., Guimaraes, C.R., Jorgensen, W.L., Cravatt, B.F. (2005) Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J. Med. Chem. 48: 1849-1856.
68. Leung, D., Du, W., Hardouin, C., Cheng, H., Hwang, I., Cravatt, B.F., Boger, D.L. (2005) Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity. Bioorg. Med. Chem. Lett. 15: 1423-1428.
69. Norris, E.H., Giasson, B.I., Hodara, R., Xu, S., Trojanowski, J.Q., Ischiropoulos, H., Lee, V.M. (2005) Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J. Biol. Chem. 280: 21212-21219.
70. Conway, K.A., Rochet, J.C., Bieganski, R.M., Lansbury, P.T., Jr. (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349.
71. Koh, B., Crews, C.M. (2002) Chemical genetics: a small molecule approach to neurobiology. Neuron 36: 563-566.
72. Stockwell, B.R. (2002) Chemical genetic screening approaches to neurobiology. Neuron 36: 559-562.
73. Huang, J., Zhu, H., Haggarty, S.J., Spring, D.R., Hwang, H., Jin, F., Snyder, M., Schreiber, S.L. (2004) Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc. Natl. Acad. Sci. USA 101: 16594-16599.
74. Xie, M.W., Jin, F., Hwang, H., Hwang, S., Anand, V., Duncan, M.C., Huang, J. (2005) Insights into TOR function and rapamycin response: chemical genomic profiling by using a high-density cell array method. Proc. Natl. Acad. Sci. USA 102: 7215-7220.
75. Kellogg, D. (2000) Chemical genetics: new tools for understanding signalling networks. Nat. Cell Biol. 2: E180-E181.
76. Shokat, K., Velleca, M. (2002) Novel chemical genetic approaches to the discovery of signal transduction inhibitors. Drug Discov. Today 7: 872-879.
77. Specht, K.M., Shokat, K.M. (2002) The emerging power of chemical genetics. Curr. Opin. Cell Biol. 14: 155-159.
78. Bishop, A.C., Shah, K., Liu, Y., Witucki, L., Kung, C., Shokat, K.M. (1998) Design of allele-specific inhibitors to probe protein kinase signaling. Curr. Biol. 8: 257-266.
79. Bishop, A.C., Shokat, K.M. (1999) Acquisition of inhibitor-sensitive protein kinases through protein design. Pharmacol. Ther. 82: 337-346.
80. Bishop, A.C., Ubersax, J.A., Petsch, D.T., Matheos, D.P., Gray, N.S., Blethrow, J., Shimizu, E., Tsien, J.Z., Schultz, P.G., Rose, M.D., Wood, J.L., Morgan, D.O., Shokat, K.M. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407: 395-401.
81. Bishop, A.C., Buzko, O., Shokat, K.M. (2001) Magic bullets for protein kinases. Trends Cell Biol. 11: 167-172.
82. Sreenivasan, A., Bishop, A.C., Shokat, K.M., Kellogg, D.R. (2003) Specific inhibition of Elm1 kinase activity reveals functions required for early G1 events. Mol. Cell Biol. 23: 6327-6337.
83. Jacobson, KA, Gao, Z.G., Chen, A., Barak, D., Kim, S.A., Lee, K., Link, A., Rompaey, P.V., van Calenbergh, S., Liang et al. (2001) Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. Journal Of Medicinal Chemistry 44: 4125-4136.
84. Peet, D.J., Doyle, D.F., Corey, D.R., Mangelsdorf, D.J. (1998) Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR. Chemistry & Biology 5: 13-21.
85. Koh, J.T., Putnam, M., Tomic-Canic, M., McDaniel, C.M. (1999) Selective regulation of gene expression using rationally-modified retinoic acid receptors. Journal of the American Chemical Society 121: 1984-1985.
86. Tedesco, R., Thomas, JA, Katzenellenbogen, B.S., Katzenellenbogen, JA (2001) The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations. Chemistry & Biology 8: 277-287.
87. Coward, P., Wada, H.G., Falk, M.S., Chan, S.D., Meng, F., Akil, H., Conklin, B.R. (1998) Controlling signaling with a specifically designed Gi-coupled receptor. PNAS 95: 352-357.
88. Redfern, C.H., Coward, P., Degtyarev, M.Y., Lee, E.K., Kwa, A.T., Hennighausen, L., Bujard, H., Fishman, G.I., Conklin, B.R. (1999) Conditional expression and signaling of a specifically designed G(i)-coupled receptor in transgenic mice. Nature Biotechnology 17: 165-169.
89. Peterson, J.R., Lokey, R.S., Mitchison, T.J., Kirschner, M.W. (2001) A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. Proc. Natl. Acad. Sci. USA 98: 10624-10629.
90. Brozinick, J.T., Jr., Hawkins, E.D., Strawbridge, A.B., Elmendorf, J.S. (2004) Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues. J. Biol. Chem. 279: 40699-40706.
91. Scarpi, D., McBride, J.D., Leatherbarrow, R.J. (2004) Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived pep tides: creation of a new tri-functional inhibitor. Bioorg. Med. Chem. 12: 6045-6052.
92. Jaulent, A.M., Leatherbarrow, R.. (2004) Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors. Protein Eng. Des. Sel. 17: 681-687.
93. Brauer, A.B., Kelly, G., McBride, J.D., Cooke, R.M., Matthews, S.., Leatherbarrow, R.. (2001) The Bowman-Birk inhibitor reactive site loop sequence represents an independent structural beta-hairpin motif. J. Mol.Biol. 306: 799-807.
94. Hagen, V., Dzeja, C., Frings, S., Bendig, J., Krause, E., Kaupp, U.B. (1996) Caged compounds of hydrolysis-resistant analogues of cAMP and cGMP: synthesis and application to cyclic nucleotide-gated channels. Biochemistry 35: 7762-7771.
95. Aarhus, R., Gee, K., Lee, H.C. (1995) Caged cyclic ADP-ribose. Synthesis and use. J. Biol Chem. 270: 7745-7749.
96. Goldman, Y.E., Hibberd, M.G., McCray, J.A., Trentham, D.R. (1982) Relaxation of muscle fibres by photolysis of caged ATP. Nature 300: 701-705.
97. Bettache, N., Carter, T., Corrie, J.E., Ogden, D., Trentham, D.R. (1996) Photolabile donors of nitric oxide: ruthenium nitrosyl chlorides as caged nitric oxide. Methods Enzymol. 268: 266-281.
98. Montgomery, H.J., Perdicakis, B., Fishlock, D., Lajoie, G.A., Jervis, E., Guy, G.J. (2002) Photo-control of nitric oxide synthase activity using a caged isoform specific inhibitor. Bioorg. Med. Chem. 10: 1919-1927.
99. Grewer, C., Jager, J., Carpenter, B.K., Hess, G.P. (2000) A new photolabile precursor of glycine with improved properties: A tool for chemical kinetic investigations of the glycine receptor. Biochemistry 39: 2063-2070.
100. Morad, M., Davies, N.W., Kaplan, J.H., Lux, H.D. (1988) Inactivation and block of calcium channels by photo-released Ca2+ in dorsal root ganglion neurons. Science 241: 842-844.
101. Grell, E., Lewitzki, E., Ruf, H., Bamberg, E., Ellis-Davies, G.G., Kaplan, J.H., de, W.P. (1989) Caged-Ca2+: a new agent allowing liberation of free Ca2+ in biological systems by photolysis. Cell Mol. Biol. 35: 515-522.
102. Goedhart, J., Gadella, T.W., Jr. (2004) Photolysis of caged phosphatidic acid induces flagellar excision in Chlamydomonas. Biochemistry 43: 4263-4271.
103. Khodakhah, K., Armstrong, C.M. (1997) Induction of long-term depression and rebound potentiation by inositol trisphosphate in cerebellar Purkinje neurons. Proc. Natl. Acad. Sci. USA 94: 14009-14014.
104. Li, W., Llopis, J., Whitney, M., Zlokarnik, G., Tsien, R.Y. (1998) Cell-permeant caged InsP3 ester shows that Ca2+ spike frequency can optimize gene expression. Nature 392: 936-941.
105. Samways, D.S., Li, W.H., Conway, S.J., Holmes, A.B., Bootman, M.D., Henderson, G. (2003) Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization. Biochem. J. 375: 713-720.
106. Walker, J.W., Feeney, J., Trentham, D.R. (1989) Photolabile precursors of inositol phosphates. Preparation and properties of 1-(2-nitrophenyl)ethyl esters of myo-inositol 1,4,5-trisphosphate. Biochemistry 28: 3272-3280.
107. Wang, S.S., Augustine, G.J. (1995) Confocal imaging and local photolysis of caged compounds: dual probes of synaptic function. Neuron 15: 755-760.
108. Pan, P., Bayley, H. (1997) Caged cysteine and thiophosaphoryl peptides. FEBS Lett. 405: 81-85.
109. Tatsu, Y., Nishigaki, T., Darszon, A., Yumoto, N. (2002) A caged sperm-activating peptide that has a photocleavable protecting group on the backbone amide. FEBS Lett. 525: 20-24.
110. Walker, J.W., Gilbert, S.H., Drummond, R.M., Yamada, M., Sreekumar, R., Carraway, R.E., Ikebe, M., Fay, F.S. (1998) Signaling pathways underlying eosinophil cell motility revealed by using caged peptides. Proc. Natl. Acad. Sci. USA 95: 1568-1573.
111. Chang, C.Y., Niblack, B., Walker, B., Bayley, H. (1995) A photogenerated pore-forming protein. Chem. Biol. 2: 391-400.
112. Marriott, G., Heidecker, M. (1996) Light-directed generation of the actin-activated ATPase activity of caged heavy meromyosin. Biochemistry 35: 3170-3174.
113. Roy, P., Rajfur, Z., Jones, D., Marriott, G., Loew, L., Jacobson, K. (2001) Local photorelease of caged thymosin beta4 in locomoting keratocytes causes cell turning. J. Cell Biol. 153: 1035-1048.
114. Ando, H., Furuta, T., Tsien, R.Y., Okamoto, H. (2001) Photo-mediated gene activation using caged RNA/DNA in zebrafish embryos. Nat. Genet. 28: 317-325.
115. Meldrum, R.A., Shall, S., Wharton, C.W. (1990) Kinetics and mechanism of DNA repair. Evaluation of caged compounds for use in studies of u.V.-induced DNA repair. Biochem. J. 266: 891-895.
116. Nguyen, A., Rothman, D.M., Stehn, J., Imperiali, B., Yaffe, M.B. (2004) Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and S-phase checkpoint function. Nat. Biotechnol. 22: 993-1000.
117. Mok, K.C., Wingreen, N.S., Bassler, B.L. (2003) Vibrio harveyi quorum sensing: a coincidence detector for two autoinducers controls gene expression. EMBO J. 22: 870-881.
118. Xavier, K.B., Bassler, B.L. (2005) Regulation of uptake and processing of the quorum-sensing autoinducer AI-2 in Escherichia coli. J. Bacteriol 187: 238-248.
119. Taga, M.E., Bassler, B.L. (2003) Chemical communication among bacteria. Proc. Natl. Acad. Sci. USA 100 Suppl 2: 14549-14554.
120. Sperandio, V., Torres, A.G., Jarvis, B., Nataro, J.P., Kaper, J.B. (2003) Bacteria-host communication: the language of hormones. Proc. Natl. Acad. Sci. USA 100: 8951-8956.
121. Surpin, M., Raikhel, N. (2004) Traffic jams affect plant development and signal transduction. Nat. Rev. Mol. Cell Biol. 5: 100-109.
122. Yeh, J.R., Crews, C.M. (2003) Chemical genetics: adding to the developmental biology toolbox. Dev. Cell 5: 11-19.
123. Jessen, K.A., English, N.M., Yu, W.J., Maliartchouk, S., Archer, S.P., Qiu, L., Brand, R., Kuemmerle, J., Zhang, H.Z., Gehlsen, K., Drewe, J., Tseng, B., Cai, S.X., Kasibhatla, S. (2005) The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach. Mol. Cancer Ther. 4: 761-771.
124. Jackson, R.W., Gelinas, R., Baughman, T.A., Cox, T., Howbert, J.J., Kucera, K.A., Latham, J.A., Ramsdell, F., Singh, D., Darwish, I.S. (2002) Benzobicyclooctanes as novel inhibitors of TNF-alpha signaling. Bioorg. Med. Chem. Lett. 12: 1093-1097.
125. Flaumenhaft, R., Sim, D.S. (2003) The platelet as a model for chemical genetics. Chem. Biol. 10: 481-486.
126. Breitkreutz, B.J., Stark, C., Tyers, M. (2003) The GRID: The General Repository for Interaction Datasets. Genome Biology 4: R23.
127. Walters, W.P., Ajay, Murcko, M.A. (1999) Recognizing molecules with drug-like properties. Curr. Opin. Chem. Biol. 3: 384-387.
128. Lipinski, C.A. (2000) Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44: 235-249.
129. Lipinski, C.A. (2003) Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov. Today 8: 12-16.
130. Derossi, D., Chassaing, G., Prochiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8: 84-87.